Proluo Pharmaceutical: Prompt Announcement on the Continuation of Separation and Changes in Equity of 5% or More Shareholders

SZSI · Dec 15, 2023 00:00

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.